Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing

Fig. 2

Flow cytometric analyses of sl-HCs at p3. The histiocytes markers analyzed were CD1a and CD207 (langerin). The study was performed for RAB-1 cells (a-c), HAN-1 (d-f), and CHR-1 (g-i). The obtained data were used for comparative analysis. Columns with bars represent mean value ± SD. Statistical differences were indicated: * p-value < 0.05, ** p-value < 0.01, and ****p-value < 0.0001, while the “ns” symbol refers to non-significant differences

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us